Correlation Between Alphabet and Isracann Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alphabet and Isracann Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Isracann Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Isracann Biosciences, you can compare the effects of market volatilities on Alphabet and Isracann Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Isracann Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Isracann Biosciences.

Diversification Opportunities for Alphabet and Isracann Biosciences

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Alphabet and Isracann is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Isracann Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Isracann Biosciences and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Isracann Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Isracann Biosciences has no effect on the direction of Alphabet i.e., Alphabet and Isracann Biosciences go up and down completely randomly.

Pair Corralation between Alphabet and Isracann Biosciences

Given the investment horizon of 90 days Alphabet is expected to generate 25.21 times less return on investment than Isracann Biosciences. But when comparing it to its historical volatility, Alphabet Inc Class C is 39.3 times less risky than Isracann Biosciences. It trades about 0.06 of its potential returns per unit of risk. Isracann Biosciences is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1.10  in Isracann Biosciences on September 2, 2024 and sell it today you would lose (1.10) from holding Isracann Biosciences or give up 100.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

Alphabet Inc Class C  vs.  Isracann Biosciences

 Performance 
       Timeline  
Alphabet Class C 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Alphabet Inc Class C are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting basic indicators, Alphabet may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Isracann Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Isracann Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Alphabet and Isracann Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alphabet and Isracann Biosciences

The main advantage of trading using opposite Alphabet and Isracann Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Isracann Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Isracann Biosciences will offset losses from the drop in Isracann Biosciences' long position.
The idea behind Alphabet Inc Class C and Isracann Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities